Paige Martin
Associate Scientific Director Critical Path Institute (C-Path)
Paige Martin, PhD is Associate Scientific Director of the Duchenne Regulatory Science Consortium (D-RSC) at the Critical Path Institute (C-Path), where she works to advance regulatory science and accelerate therapeutic development for Duchenne muscular dystrophy through collaborative data-sharing and drug development initiatives. Dr. Martin brings a strong background in rare disease research, neurogenetics, and translational science. Prior to joining C-Path, she held several roles at The Jackson Laboratory, spanning postdoctoral research, scientific information, and product development. She earned her PhD in Biomedical Science with a focus on Neurogenetics from the University of Maine. Passionate about improving outcomes for patients with rare diseases, Paige is dedicated to fostering cross-sector collaboration that enables more efficient and effective drug development.
Seminars
- Characterizing disease progression in Duchenne using longitudinal natural history and clinical trial data to better understand variability, trajectories, and relationships across clinically meaningful outcomes
- Using disease progression models and clinical trial simulation to inform decisions around endpoint selection, eligibility criteria, study duration, sample size, and other key trial design assumptions
- Applying model-informed drug development approaches to reduce development uncertainty, support more evidence-based decision-making, and strengthen regulatory interactions
